The clinical trial for INS115644 (latrunculin B; Inspire Pharmaceuticals) for safety and elevated intraocular pressure in glaucoma was completed September 9, 2009  (clinical trial NCT00443924).  No safety issues were found.  Read more at http://clinicaltrials.gov/ct2/show/study/NCT00443924?term=INS115644&rank=1.

This entry was posted on Wednesday, August 11th, 2010 at 10:14 pm and is filed under Natural Products News. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.